VEA
RARX

Virtus ETF Advisers’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Virtus ETF Advisers’s Portfolio RARX Stock Details RARX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
2020
Q1 		$365K Sell
2019
Q4 		$410K Sell
2019
Q3 		$281K Sell
2019
Q2 		$377K Sell
2019
Q1 		$363K Sell
2018
Q4 		$325K Buy